Owner Bayer Pharmaceuticals Corporation

Inventors Fan, Jianmei; Phillips, Barton; Scott, William J.; Chen, Yuanwei; Chen, Zhi; Redman, Aniko; Dumas, Jacques; Lee, Wendy; Chen, Jianqing; Yi, Lin; Boyer, Stephen; Raudenbush, Brian; Verma, Sharad; Zhu, Qingming

Agent Cullens

Pub. Number AU-B-2004217977

PCT Pub. Number WO2004/078747

Priority 60/450,323 28.02.03 US; 60/450,348 28.02.03 US; 60/450,324 28.02.03 US

Filing date 1 March 2004

Wipo publication date 16 September 2004

Acceptance publication date 1 April 2010

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/443 (2006.01)

A61K 31/4433 (2006.01)

A61K 31/4436 (2006.01)

A61K 31/444 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 213/68 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/79 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/84 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group